According to US Food and Drug Administration (USFDA), Zydus Pharmaceuticals USA Inc, the US-based arm of Cadila Healthcare, is recalling 58,920 bottles of benzonatate capsules, used to treat coughs, because of ''wet and/or leaking capsules''.

The recall had been initiated on Nov. 26, 2014 under Class-II, which the FDA states as a situation in which the use of or exposure to a volatile product may cause temporary or medically reversible adverse health consequences.

Commenting on the result, Sarabjit Kour Nangra, VP research, pharma, Angel Broking, said, ''The capsules have been manufactured by Ahmedabad-based Cadila Healthcare and distributed by Zydus Pharmaceuticals USA. Further, Hospira is recalling 2,61,706 vials of meropenem, an antibiotic, in the US, Puerto Rico, Italy, the Netherlands and Spain for having ''defective container''. We don't expect the development to have an adverse impact on the company's operation. We remain neutral on the stock.''

Disclaimer: IRIS has taken due care and caution in compilation of data for its web site. Information has been obtained by IRIS from sources which it considers reliable. However, IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website.